EX-10.6 5 btmd-ex10_6.htm EX-10.6 EX-10.6

展覽10.6

 

執行版本

信貸協議的第二次修正

這第二項信貸協議修正案(本“協議”,日期爲2024年6月26日(本“本次第二次修正將在每個以下條件滿足時生效:,由 BIOTE 醫療有限責任公司(一家德克薩斯州有限責任公司)及 BIOTE 控股有限責任公司(一家特拉華州有限責任公司)等簽署。借款人,一家特拉華州有限責任公司Holdings),其他擔保方,貸款方以及作爲行政代理的Truist銀行(“行政代理人”).

 

鑑於,計劃第17.2節保留了Celldex Therapeutics,Inc.(以下稱爲「公司」)董事會(以下稱爲「董事會」)修訂計劃的權利;和

 

鑑於,借款人、控股公司、其他擔保方、貸款人和管理代理已經簽訂了某項信貸協議,日期爲2022年5月26日(被修訂、重訂、被修訂和重訂、補充、增加、延長、再融資、續約、更換和/或以書面形式不時修改的,該“授信協議 (Credit Agreement)”);

鑑於借款人請求出借人按照下文規定修改信貸協議,但須遵守本協議中規定的條款和條件;以及

鑑於,貸款人(構成必要貸款人和必要循環貸款人的貸款人行爲)已同意根據本文所載條款和條件對信貸協議進行所請求的修訂。

現在,鑑於本協議所載內容併爲其他有價值的考慮,茲特確認各方已收到並認可足額,特此各方一致同意如下:

 

協議

 

1.
介紹性段落和背景資料; 定義上述介紹性段落和背景資料(包括其中定義的任何條款)已被引用並作爲本協議的一部分納入,如同完整地載於本協議正文。本協議中使用但未在此處另有定義的大寫詞彙,應當具有在信貸協議中所賦予的相應含義(本協議對該協議進行了修訂,或在本協議生效之前立即生效的情況下,根據情境可能需要的效力)。
2.
信用協議修訂事項根據信貸協議第11.2節的規定,經構成必要貸款人和必要循環貸款人的貸款人行爲,信貸協議如下進行修改:放棄; 修訂根據信貸協議第11.2節的規定,經構成必要貸款人和必要循環貸款人的貸款人行爲,信貸協議如下進行修改:
(a)
“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:定義“貸款協議第1.1節中""Consolidated Fixed Charges""的定義中的第(b)款被完全修改如下:
(b)
在此期間就《合併總債務》支付的正常計劃本金還款(排除義務性預付款項)進行支付(爲避免疑問,不包括(i)根據 第2.12節。(ii)對循環貸款(包括但不限於循環貸款)的還款,不導致承諾減少的範圍內,(iii) Holdings及其子公司之間的母公司債務的支付,以及(iv)根據Donovitz和Marci和解協議,父公司回購資本股的支付。 '第7.5(d)條')以及在該期間由控股及其子公司以現金支付的資本租賃債務,每種情況都以最近結束的四(4)個財務季度的合併基礎進行衡量。四(4)個最近結束的財政季度期間,按合併基礎衡量控股及其子公司支付的《資本租賃租約》款項。

 

 


(b)
信貸協議的1.1節(定義)被修改以按照適當的字母順序插入以下定義的術語:

馬爾奇和解協議”表示某項和解協議,將在2024年6月28日左右生效,當事人包括 inter alios、母公司和Marci M. Donovitz。

(c)
在信貸協議的1.1節(定義)中,“?重要一節 協議”的定義在此完全修改如下:

重要協議“應指(i)管理任何負債的所有協議、契約或票據所規定的條款,(ii)Donovitz和解協議,(iii)Marci和解協議以及(iv)所有其他協議、文件、合同、契約和工具,根據這些協議,(A)任何貸款方或其子公司在任何12個月期間有義務支付超過臨界金額、(B)任何貸款方或其子公司預計在任何12個月期間收入超過臨界金額,並且(C)其違約、違約或終止合同可能會合理預期導致重大不利影響。

(d)
第 7.5 節中的 (d) 條款 (限制性付款)特此對信貸協議進行全面修訂,內容如下:
(d)
根據Donovitz結算協議的約定,父公司回購資本股票的支付金額分別爲(A)32,162,261.67美元,Donovitz結算協議生效日期後第三個營業日(即“Donovitz結算協議結案日期(B)15,081,130.83美元,Donovitz結算協議結案日期之前或之日,(C)19,081,130.83美元,Donovitz結算協議結案日期滿24個月之前或之時,以及(D) 10,540,565.42美元,Donovitz結算協議結案日期滿36個月之前或之時;根據Marci結算協議的約定,回購資本股票的支付金額分別爲(A)30,000,000.00美元,Marci結算協議生效日期(即“Marci結算協議 結案日期,(B)10,000,000.00美元,Marci結算協議結案日期之前或之日,(C)10,000,000.00美元,Marci結算協議結案日期滿24個月之前或之時,以及(D)10,000,000.00美元,Marci結算協議結案日期滿36個月之前或之時;
3.
有效性; 控件前提條件本協議應在第二修訂生效日期起通過行政代理人收到行政代理人、構成必要貸款人和必要循環貸款人的借款人、控股公司和其他擔保人簽署的本協議副本後生效。
4.
其他.
(a)
本協議應被視爲並且是一份貸款文件。
(b)
自第二修正生效日期起,所有貸款文件中關於信貸協議的引用應特指本協議修正後的信貸協議。
(c)
除非本協議另有明示修改,信貸協議、貸款文件和每個貸款方在此項下及其他貸款文件項下的義務均經此批准和確認,並應根據各自的條款繼續有效且保持完全有效。
(d)
貸款方中的每一方: (i) 承認並同意本協議的所有條款和條件; (ii) 同意本協議及與本協議有關的所有文件的內容, 未授予用於減少或清償其在信貸協議或其他貸款中的任何義務。

2


文件,或任何證書、文件、協議和/或與之或相關的文件;(iii)確認其在貸款文件項下的所有義務;(iv)同意本協議不得以任何方式損害或對任何貸款文件中授予的任何留置權產生不利影響;及(v)確認任何貸款文件中授予的每項留置權都是有效且存在。
(e)
Each of the Loan Parties hereby represents and warrants to the Administrative Agent and each of the Lenders as follows:
(i)
such Loan Party has taken all necessary action to authorize the execution, delivery and performance of this Agreement;
(ii)
this Agreement has been duly executed and delivered by such Loan Party and constitutes such Loan Party’s legal, valid and binding obligations, enforceable in accordance with its terms;
(iii)
no consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by any Loan Party of this Agreement;
(iv)
after giving effect to this Agreement, all representations and warranties of each Loan Party set forth in the Loan Documents are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) except to the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) as of such earlier date; and
(v)
after giving effect to this Agreement, no Default or Event of Default exists.
(f)
This Agreement may be executed by one (1) or more of the parties to this Agreement on any number of separate counterparts (including by telecopy), and all of said counterparts, taken together, shall be deemed to constitute one (1) and the same instrument. Delivery of an executed counterpart of a signature page of this Agreement by facsimile transmission or by any other electronic imaging means (including in “.pdf” form), shall be effective as delivery of a manually executed counterpart of this Agreement.
(g)
THIS AGREEMENT, AND ANY CLAIMS, CONTROVERSIES, DISPUTES OR CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF, OR RELATING TO THIS AGREEMENT, AND/OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE CONSTRUED IN ACCORDANCE WITH, AND BE GOVERNED BY, THE LAWS (WITHOUT GIVING EFFECT TO THE CONFLICT OF LAW PRINCIPLES THEREOF) OF THE STATE OF NEW YORK.
5.
Reaffirmation of Obligations. Each of the Loan Parties: (a) acknowledges and consents to all of the terms and conditions of this Agreement; (b) affirms all of its obligations under the Loan Documents (as amended by this Agreement); and (c) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not operate to reduce or discharge such Loan Party’s obligations under the Loan Documents (except to the extent that such obligations are expressly modified pursuant to this Agreement).

3


6.
Reaffirmation of Security Interests. Each of the Loan Parties: (a) affirms that each of the Liens granted in, or pursuant to, any of the Loan Documents is valid and subsisting; and (b) agrees that this Agreement, and all documents, agreements and instruments executed in connection with this Agreement, do not, in any manner, impair, or otherwise adversely affect, any of the Liens granted in, or pursuant to, any of the Loan Documents.
7.
No Other Changes. Except as expressly modified hereby, all of the terms and provisions of the Loan Documents shall remain in full force and effect.

 

[Remainder of Page Intentionally Left Blank; Signature Pages Follow]

4


 

IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered by their respective authorized officers as of the day and year first above written.

 

BORROWER:

BIOTE MEDICAL, LLC,

 

a Texas limited liability company

 

 

 

 

By:

BIOTE HOLDINGS, LLC, its Sole Member

 

By:

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

By:

/s/ Robert Peterson

 

Name:

Robert Peterson

 

Title:

Chief Financial Officer

 

 

 

 

 

 

GUARANTORS:

BIOTE HOLDINGS, LLC,

 

a Delaware limited liability company

 

 

 

 

By:

BIOTE CORP., its Managing Member

 

 

 

 

 

 

 

By:

/s/ Robert Peterson

 

Name:

Robert Peterson

 

Title:

Chief Financial Officer

 

 

 

 

 

 

 

BIOTE IP, LLC,

 

a Nevada limited liability company

 

 

 

 

By:

/s/ Robert Peterson

 

Name:

Robert Peterson

 

Title:

Chief Financial Officer

 

 


 

ADMINISTRATIVE AGENT: TRUIST BANK,

 

 

as the Administrative Agent

 

 

 

 

 

 

 

By:

/s/ Troy R. Weaver

 

Name:

Troy R. Weaver

 

Title:

Managing Director

 

 


 

 

LENDERS:

TRUIST BANK,

 

as a Lender, the Issuing Bank and the Swingline Lender

 

 

 

 

 

By:

/s/ Troy R. Weaver

 

Name:

Troy R. Weaver

 

Title:

Managing Director

 

 


 

 

 

BANK OF AMERICA, N.A.,

 

as a Lender

 

 

 

 

 

By:

/s/ Alexander L. Rody

 

Name:

Alexander L. Rody

 

Title:

Senior Vice President

 

 


 

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION,

 

as a Lender

 

 

 

 

 

By:

/s/ Alexander L. Rody

 

Name:

Ashley Griffith

 

Title:

Vice President